PS Ratio Chart

View PS Ratio for TLRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2018. Start Trial.
Date Value
August 31, 2026 0.5548
August 28, 2026 0.5572
August 27, 2026 0.5548
August 26, 2026 0.5633
August 25, 2026 0.5924
August 24, 2026 0.573
August 21, 2026 0.5876
August 20, 2026 0.567
August 19, 2026 0.5864
August 18, 2026 0.5427
August 17, 2026 0.5439
August 14, 2026 0.567
August 13, 2026 0.5706
August 12, 2026 0.5682
August 11, 2026 0.5803
August 10, 2026 0.5366
August 07, 2026 0.5548
August 06, 2026 0.539
August 05, 2026 0.5372
August 04, 2026 0.5633
August 03, 2026 0.5633
July 31, 2026 0.5512
July 30, 2026 0.5099
July 29, 2026 0.4844
July 28, 2026 0.4893
Date Value
July 27, 2026 0.4893
July 24, 2026 0.471
July 23, 2026 0.4844
July 22, 2026 0.505
July 21, 2026 0.5148
July 20, 2026 0.5135
July 17, 2026 0.522
July 16, 2026 0.5281
July 15, 2026 0.5317
July 14, 2026 0.5317
July 13, 2026 0.5415
July 10, 2026 0.5366
July 09, 2026 0.533
July 08, 2026 0.5305
July 07, 2026 0.5232
July 06, 2026 0.5317
July 02, 2026 0.5609
July 01, 2026 0.5378
June 30, 2026 0.5451
June 29, 2026 0.5597
June 26, 2026 0.5633
June 25, 2026 0.5415
June 24, 2026 0.5572
June 23, 2026 0.5597
June 22, 2026 0.5572

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
SNDL, Inc. 0.5298
cbdMD, Inc. 0.2281
Clearmind Medicine, Inc. --
CannaPharmaRx, Inc. 0.9433
Cosmos Health, Inc. 0.1397

PS Ratio Related Metrics

Price to Book Value 0.3711
Price 4.57
Earnings Yield -23.53%
Market Cap 599.10M